FTO and ovarian carcinoma: (48) documented a pronounced upregulation of FTO gene expression in tissue samples derived from human ovarian tumors, illustrating its significant involvement in promoting phosphorylation processes, particularly of the RAC-alpha serine/threonine-protein kinase (AKT) in ovarian cancer cells.